8-K
GoodRx Holdings, Inc. Announces Non-Reliance on Financial Statements for Q1 and Q2 2026 Due to Understated Pharma Direct Revenue
8-K
GoodRx Holdings, Inc. Announces CFO Transition
8-K
GoodRx Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance
8-K
GoodRx Holdings, Inc. Announces Results of 2026 Annual Meeting of Stockholders
8-K
GoodRx Reports First Quarter 2026 Financial Results and Raises Full Year Guidance
8-K
GoodRx Holdings, Inc. Appoints Thomas Chan as Chief Accounting Officer
